Category: General

Aurora Cannabis Completes Strategic Investment in Micron Waste Technologies

SHARE THIS POST Companies Finalize Collaboration Agreement EDMONTON and VANCOUVER, Jan. 15, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Micron Waste Technologies Inc. (“Micron”) (CSE: MWM, OTC: MICWF, Frankfurt: 7FM2), a developer of proprietary digester solutions for the treatment of organic waste, today announced that Aurora has completed a strategic investment in Micron and that the companies have finalized a collaboration agreement pursuant to which both companies will collaborate on the optimization of Micron’s technology for the treatment of organic waste generated in the cultivation and production of cannabis products. Micron has developed a new technology, based on aerobic digestion and subsequent treatment, that converts organic waste into clean water that meets municipal effluent discharge standards. Currently used methods to dispose of organic waste generally require the utilization of municipal landfill sites, which is costly and has a negative impact on the environment. The merits of Micron’s technology have been successfully demonstrated with a grocery supermarket chain located in British Columbia, Canada, with whom Micron has entered into an Memorandum of Understanding to review additional installations. Micron will now install a digester unit at one of Aurora`s facilities, where the companies will jointly work to optimize the digestor for the cannabis industry. Upon successful completion of the project, Aurora intends to acquire multiple units for its various facilities. Micron will retain the...

Read More

Week in Review – Week Ended January 12, 2018

SHARE THIS POST On January 4, 2018, Attorney General Jeff Session announced that the Trump Administration is rescinding the Cole Memo, which creates significant uncertainty about the regulatory environment at the state level. Early Responses Bridget Hill-Zayat, Esq., of Cannabis Law Firm, Hoban Law Group, said that “The status of the law remains unchanged. Cannabis was always federally illegal, and there was always a conflict of state and federal law. Replacing the Cole Memo is wildly unpopular with both Democrats and Republicans. This move by Sessions creates a hurdle for sure, but as long as there are veterans and patients, it will remain political suicide for federally elected leaders to support further prohibition. To that end, Governor Wolf of Pennsylvania today announced he plans to protect patients. Indeed, Colorado Senator Cory Gardner said he would hold up Trump’s DOJ nominations over this policy shift. The state will fight back and so will voters in the next election.” Justin Hobson, Co-Chair Cannabis Group, Lane Powell (Seattle & Portland), said that “This development, while anticipated for some time, could have a significant effect on cannabis markets, and especially on the financing of cannabis businesses. The action also provides the possibility for U.S. Attorneys to take aggressive actions against industry participants. It is too early to say what might happen with this rescission, but needless to say people in the industry should...

Read More

Future Farm Signs LOI to Acquire Controlling Interest in Massachusetts Dispensary and Grow Operation

SHARE THIS POST January 11, 2017 – Vancouver, British Columbia – Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that it has signed a LOI to acquire a 51% interest in Bristol County Wellness Center, Inc. (“BCWC”). BCWC was recently awarded a special permit from the City of Attleboro and a provisional license from the Department of Public Health to build and operate a 24,700-sq ft. Registered Marijuana Dispensary (“RMD”) that will grow and sell medical marijuana, plus two additional dispensaries upon approval. This vertically integrated license allows BCWC to build out its facility and engage in cannabis cultivation, processing and retailing. William Gildea, CEO of Future Farm comments, “We are pleased to be working with the experienced team at BCWC, and thrilled about the potential to operate in Massachusetts since it further positions our Company for revenue growth in 2018.” He continues, “This transaction allows us to operate in a state that has approved, but not yet implemented, the recreational use of cannabis, which positions us as one of the first movers in the state.”  In Massachusetts, licensed RMDs applying for an adult use license will be given prioritized application review by the state. The timetable calls for construction to begin in the next thirty days, and revenue to begin in the third quarter of 2018. BCWC is provisionally...

Read More

AMENDED AND RESTATED NEWS RELEASE – Aurora Cannabis Announces Intention to Launch Takeover Bid for CanniMed Therapeutics Inc.

SHARE THIS POST This amended and restated news release is being issued pursuant to the orders (the “Orders”), dated December 22, 2017, of the Ontario Securities Commission (the “OSC”) and the Financial and Consumer Affairs Authority of Saskatchewan (the “FCAAS” and together with the OSC the “Securities Regulators”). In the section below entitled “Background to the Offer”, Aurora provides further information in response to the following disclosure required by the Orders of the Securities Regulators: The circumstances under which, and the means by which, Aurora became aware that the board of CanniMed Therapeutics Inc.  would be meeting on November 13, 2017 to, among other things, consider for approval an arrangement agreement entered into between CanniMed Therapeutics Inc. and Newstrike Resources Limited. Other information that was: (i) obtained directly or indirectly by Aurora from any person who is, or was at the relevant time, in a special relationship with CanniMed Therapeutics Inc. (by reference to the definitions in subsection 76(5) of the Securities Act (Ontario) and clause 85(1)(a) of the Securities Act (Saskatchewan)); and (ii) material to Aurora in structuring, determining the timing of, delivering or implementing the Aurora Offer. Other information within Aurora’s knowledge that would reasonably be expected to affect the decision of the security holders of CanniMed Therapeutics Inc. to accept or reject the offer made by the Aurora Offer. Aurora’s proposed offer currently valued at $24.00...

Read More

Lifestyle Delivery Systems Announces Completion of Non-Brokered Private Placement Financing and Grant of Stock Options

SHARE THIS POST Vancouver, British Columbia–(Newsfile Corp. – January 12, 2018) – Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF) (FSE: LD6) (WKN: A14XHT) (“LDS” or the “Company”) is pleased to announce that it has closed a non-brokered private placement financing (the “Financing”) of a total of 5,500,000 units (the “Units”) at a price of Cdn$0.50 per Unit (the “Issue Price”), for total gross proceeds of Cdn$2,750,000. Due to strong investor demand, the Financing was oversubscribed. Each Unit sold in the Financing consisted of one common share of the Company (each a “Unit Share”) and one common share purchase warrant (each a “Warrant”) entitling the holder to purchase one additional common share (a “Warrant Share”) at a price of $0.75 per Warrant Share for a period ending one year from the date of issuance. The Company may accelerate the expiration date of the Warrants if the daily volume weighted average share price of the Company’s common shares on the Canadian Securities Exchange (or such other stock exchange as the Company’s common shares are then trading on) is equal to or greater than Cdn$1.50 for 10 consecutive trading days. The securities issued under the Offering will be subject to a hold period expiring on May 12, 2018, pursuant to applicable Canadian securities laws. This news release does not constitute an offer to sell, or a solicitation of an offer to...

Read More

Valens Groworks Receives $602,200 From Warrant Exercise

SHARE THIS POST Vancouver, B.C., January 12, 2018 – Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multilicenced, vertically integrated provider of cannabis products, announces it has received $602,200 from the exercise of share purchase warrants. A total of 523,653 warrants were exercised at $1.15 and the Company is issuing a total of 523,653 common shares. The warrants were issued in connection with a non-brokered private placement financing in January 2017 and expired on January 11, 2018. Tyler Robson, CEO of Valens GroWorks commented: “We are very pleased with the level of support received from our shareholders as demonstrated by the closing of our recent $2,000,000 funding, as well as the exercise of these warrants. With our significantly improved treasury, Valens GroWorks is well positioned to advance its corporate initiatives.” About Valens GroWorks Corp. Valens GroWorks is Canadian publicly traded biotechnology company executing on its “plants to premium products” objectives through two wholly-owned subsidiaries located in the heart of British Columbia’s Okanagan Valley. The Company owns 100% of Valens Agritech (“VAL”), commencing cannabis production and sales under a Health Canada Dealer’s License, and a late-stage license applicant to cultivate medical marijuana under the ACMPR for individual patients. Valens also owns 100% of Supra THC Services (“Supra”), a Health Canada licensed cannabis testing lab providing sector-leading analytical and proprietary services to Licensed Producers, ACMPR patients, and the natural...

Read More